PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective
暂无分享,去创建一个
Joel H Saltz | Arvind Rao | Lee Ad Cooper | A. Rao | J. Saltz | L. Cooper | A. Lazar | E. Demicco | Reid T. Powell | Alexander J Lazar | Elizabeth G. Demicco | Reid T Powell | Elizabeth G Demicco
[1] J. Desai,et al. PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors. , 2010 .
[2] Mithat Gönen,et al. Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications , 2017, Modern Pathology.
[3] D. Stuart,et al. The evolution of melanoma resistance reveals therapeutic opportunities. , 2013, Cancer research.
[4] Mitko Veta,et al. Going fully digital: Perspective of a Dutch academic pathology lab , 2013, Journal of pathology informatics.
[5] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[6] S. Gabriel,et al. Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.
[7] E. S. Kopetz,et al. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. , 2015, Journal of gastrointestinal oncology.
[8] Tahsin Kurc,et al. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. , 2012, The American journal of pathology.
[9] Berkman Sahiner,et al. Classification of follicular lymphoma: the effect of computer aid on pathologists grading , 2015, BMC Medical Informatics and Decision Making.
[10] Nikhil Wagle,et al. Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations. , 2015, Cancer discovery.
[11] Andrew H. Beck,et al. Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.
[12] Yuri E Nikiforov,et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.
[13] Mari Mino-Kenudson,et al. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. , 2012, Cancer discovery.
[14] Cigall Kadoch,et al. Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities. , 2017, Current opinion in genetics & development.
[15] Yi Gao,et al. A Containerized Software System for Generation, Management, and Exploration of Features from Whole Slide Tissue Images. , 2017, Cancer research.
[16] M. Stratton,et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. , 2002, Cancer research.
[17] Ganesh Rao,et al. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas , 2017, Journal of pathology informatics.
[18] Jesper Molin,et al. Implementation of large-scale routine diagnostics using whole slide imaging in Sweden: Digital pathology experiences 2006-2013 , 2014, Journal of pathology informatics.
[19] S. Sahlin,et al. DNA ploidy and S-phase fraction in carcinoma of the gallbladder related to histopathology, number of gallstones and survival , 2014 .
[20] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[21] Anant Madabhushi,et al. Statistical shape model for manifold regularization: Gleason grading of prostate histology , 2013, Comput. Vis. Image Underst..
[22] Steven J. M. Jones,et al. Genomic Classification of Cutaneous Melanoma , 2015, Cell.
[23] Sanghoon Lee,et al. Interactive phenotyping of large-scale histology imaging data with HistomicsML , 2017, bioRxiv.
[24] R. Bernards,et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR , 2012, Nature.
[25] Benjamin J. Raphael,et al. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.
[26] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[27] K. Flaherty,et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.
[28] Cynthia Cohen,et al. Whole Slide Imaging for Analytical Anatomic Pathology and Telepathology: Practical Applications Today, Promises, and Perils. , 2017, Archives of pathology & laboratory medicine.
[29] Joel H. Saltz,et al. Research and applications: Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data , 2013, J. Am. Medical Informatics Assoc..
[30] Steven J. M. Jones,et al. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas , 2017, Cell.
[31] T. Helliwell,et al. Morphometric analysis, ploidy and response to chemotherapy in squamous carcinomas of the head and neck. , 1989, Pathology, research and practice.
[32] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[33] Aleix Prat Aparicio. Comprehensive molecular portraits of human breast tumours , 2012 .
[34] Steven J. M. Jones,et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.
[35] A. Rashid,et al. Histopathological identification of colon cancer with microsatellite instability. , 2001, The American journal of pathology.
[36] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[37] M. Brose,et al. Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial. , 2016, The Lancet. Oncology.
[38] Steven J. M. Jones,et al. Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.
[39] Karsten Schlüns,et al. Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. , 2009, Lung cancer.
[40] Anant Madabhushi,et al. Adaptive Energy Selective Active Contour with Shape Priors for Nuclear Segmentation and Gleason Grading of Prostate Cancer , 2011, MICCAI.
[41] Ewert Bengtsson,et al. Screening for Cervical Cancer Using Automated Analysis of PAP-Smears , 2014, Comput. Math. Methods Medicine.
[42] Ellery Wulczyn,et al. Deep learning-based survival prediction for multiple cancer types using histopathology images , 2019, PloS one.
[43] Alexander V Penson,et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. , 2018, Cancer cell.
[44] Chao Wang,et al. Identifying survival associated morphological features of triple negative breast cancer using multiple datasets , 2013, Journal of the American Medical Informatics Association : JAMIA.
[45] Yi Gao,et al. Towards Generation, Management, and Exploration of Combined Radiomics and Pathomics Datasets for Cancer Research , 2017, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[46] Steven J. M. Jones,et al. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.
[47] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[48] Jeffrey Weber,et al. Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] Rehan Akbani,et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. , 2017, Cancer cell.
[50] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[51] M. Sperandio,et al. Heterogeneity, histological features and DNA ploidy in oral carcinoma by image-based analysis. , 2005, Oral oncology.
[52] A. Hauschild,et al. Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[53] D. Grignon,et al. Primary sarcomas of the kidney. A clinicopathologic and dna flow cytometric study of 17 cases , 1990, Cancer.
[54] Jun Kong,et al. Computerized Pathological Image Analysis For Neuroblastoma Prognosis , 2007, AMIA.